The Role of CD36 in the Effect of Arginine in Atherosclerotic Rats

Med Sci Monit. 2015 May 24:21:1494-9. doi: 10.12659/MSM.893388.

Abstract

Background: The aim of this study was to investigate the effects of arginine in the development of atherosclerosis in rats fed a high-fat diet supplemented with arginine and to evaluate the role of CD36 in this process.

Material and methods: A total of 40 Sprague-Dawley rats were randomly assigned to 4 groups: control group, fat diet group, simvastatin group, and arginine group. They were fed for 12 weeks and were then sacrificed. Immunohistochemical CD36 expression and pathology was investigated in the aorta; CD36 expression in mononuclear cells was detected by Western blot and RT-PCR.

Results: The thickness of the aortal intima, media, and I/M significantly decreased in the arginine group rats compared with those in the fat diet group (P<0.05). CD36 expression was up-regulated in rats in the fat diet group compared with the control group and was down-regulated in rats in the arginine group compared with rats in the fat diet group.

Conclusions: The addition of arginine has a significant effect on reducing rat atherosclerosis development, which may be attributed to both the down-regulation of CD36 expression in rat aortic endothelial and blood mononuclear cells and the NO pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aorta / pathology
  • Arginine / administration & dosage
  • Arginine / pharmacology*
  • Atherosclerosis / prevention & control*
  • Blotting, Western
  • CD36 Antigens / metabolism*
  • Diet, High-Fat / adverse effects*
  • Dietary Supplements
  • Female
  • Immunohistochemistry
  • Male
  • Rats
  • Reverse Transcriptase Polymerase Chain Reaction
  • Statistics, Nonparametric
  • Tunica Intima / pathology

Substances

  • CD36 Antigens
  • Cd36 protein, rat
  • Arginine